Evaluation of serum anti-Mullerian hormone levels to assess the ovarian reserve in women with severe endometriosis

Arianna Pacchiarotti, Paola Frati, Giusi Natalia Milazzo, Angelica Catalano, Vincenzo Gentile, Massimo Moscarini

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Objective The aim of this study was to measure anti-Mullerian hormone (AMH) serum levels in women with severe endometriosis, in order to demonstrate the effect of the disease on ovarian reserve. Study design Prospective case-control study. One hundred and ninety-five patients were enrolled: 130 fertile patients (group A) and 65 patients with stage III and IV endometriosis, diagnosed by laparoscopy and histological examination (group B). AMH serum levels were measured in both groups and were compared using Student's t-test. Results The two groups were homogenous for main demographic data. Group B had statistically significantly lower mean AMH serum levels (0.97 ± 0.59 ng/ml) than group A (1.72 ± 0.63 ng/ml) (p = 0.001). Conclusions This study is a demonstration of the damage of endometriosis on ovarian reserve, leading to a form of incipient ovarian failure, which is considered as an early sign of advanced ovarian depletion in young women. These findings suggest that AMH could be used in the follow-up of patients with endometriosis, in order to assess promptly the decrease of ovarian reserve.

Original languageEnglish
Pages (from-to)62-64
Number of pages3
JournalEuropean Journal of Obstetrics and Gynecology and Reproductive Biology
Volume172
Issue number1
DOIs
Publication statusPublished - Jan 2014

Fingerprint

Anti-Mullerian Hormone
Endometriosis
Serum
Laparoscopy
Case-Control Studies
Demography
Prospective Studies
Students
Ovarian Reserve

Keywords

  • Anti-Mullerian hormone
  • Endometriosis
  • Ovarian failure
  • Ovarian reserve

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • Reproductive Medicine

Cite this

Evaluation of serum anti-Mullerian hormone levels to assess the ovarian reserve in women with severe endometriosis. / Pacchiarotti, Arianna; Frati, Paola; Milazzo, Giusi Natalia; Catalano, Angelica; Gentile, Vincenzo; Moscarini, Massimo.

In: European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 172, No. 1, 01.2014, p. 62-64.

Research output: Contribution to journalArticle

Pacchiarotti, Arianna ; Frati, Paola ; Milazzo, Giusi Natalia ; Catalano, Angelica ; Gentile, Vincenzo ; Moscarini, Massimo. / Evaluation of serum anti-Mullerian hormone levels to assess the ovarian reserve in women with severe endometriosis. In: European Journal of Obstetrics and Gynecology and Reproductive Biology. 2014 ; Vol. 172, No. 1. pp. 62-64.
@article{34cee505c8d947a1b589cc678f8fb29a,
title = "Evaluation of serum anti-Mullerian hormone levels to assess the ovarian reserve in women with severe endometriosis",
abstract = "Objective The aim of this study was to measure anti-Mullerian hormone (AMH) serum levels in women with severe endometriosis, in order to demonstrate the effect of the disease on ovarian reserve. Study design Prospective case-control study. One hundred and ninety-five patients were enrolled: 130 fertile patients (group A) and 65 patients with stage III and IV endometriosis, diagnosed by laparoscopy and histological examination (group B). AMH serum levels were measured in both groups and were compared using Student's t-test. Results The two groups were homogenous for main demographic data. Group B had statistically significantly lower mean AMH serum levels (0.97 ± 0.59 ng/ml) than group A (1.72 ± 0.63 ng/ml) (p = 0.001). Conclusions This study is a demonstration of the damage of endometriosis on ovarian reserve, leading to a form of incipient ovarian failure, which is considered as an early sign of advanced ovarian depletion in young women. These findings suggest that AMH could be used in the follow-up of patients with endometriosis, in order to assess promptly the decrease of ovarian reserve.",
keywords = "Anti-Mullerian hormone, Endometriosis, Ovarian failure, Ovarian reserve",
author = "Arianna Pacchiarotti and Paola Frati and Milazzo, {Giusi Natalia} and Angelica Catalano and Vincenzo Gentile and Massimo Moscarini",
year = "2014",
month = "1",
doi = "10.1016/j.ejogrb.2013.10.003",
language = "English",
volume = "172",
pages = "62--64",
journal = "European Journal of Obstetrics, Gynecology and Reproductive Biology",
issn = "0028-2243",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Evaluation of serum anti-Mullerian hormone levels to assess the ovarian reserve in women with severe endometriosis

AU - Pacchiarotti, Arianna

AU - Frati, Paola

AU - Milazzo, Giusi Natalia

AU - Catalano, Angelica

AU - Gentile, Vincenzo

AU - Moscarini, Massimo

PY - 2014/1

Y1 - 2014/1

N2 - Objective The aim of this study was to measure anti-Mullerian hormone (AMH) serum levels in women with severe endometriosis, in order to demonstrate the effect of the disease on ovarian reserve. Study design Prospective case-control study. One hundred and ninety-five patients were enrolled: 130 fertile patients (group A) and 65 patients with stage III and IV endometriosis, diagnosed by laparoscopy and histological examination (group B). AMH serum levels were measured in both groups and were compared using Student's t-test. Results The two groups were homogenous for main demographic data. Group B had statistically significantly lower mean AMH serum levels (0.97 ± 0.59 ng/ml) than group A (1.72 ± 0.63 ng/ml) (p = 0.001). Conclusions This study is a demonstration of the damage of endometriosis on ovarian reserve, leading to a form of incipient ovarian failure, which is considered as an early sign of advanced ovarian depletion in young women. These findings suggest that AMH could be used in the follow-up of patients with endometriosis, in order to assess promptly the decrease of ovarian reserve.

AB - Objective The aim of this study was to measure anti-Mullerian hormone (AMH) serum levels in women with severe endometriosis, in order to demonstrate the effect of the disease on ovarian reserve. Study design Prospective case-control study. One hundred and ninety-five patients were enrolled: 130 fertile patients (group A) and 65 patients with stage III and IV endometriosis, diagnosed by laparoscopy and histological examination (group B). AMH serum levels were measured in both groups and were compared using Student's t-test. Results The two groups were homogenous for main demographic data. Group B had statistically significantly lower mean AMH serum levels (0.97 ± 0.59 ng/ml) than group A (1.72 ± 0.63 ng/ml) (p = 0.001). Conclusions This study is a demonstration of the damage of endometriosis on ovarian reserve, leading to a form of incipient ovarian failure, which is considered as an early sign of advanced ovarian depletion in young women. These findings suggest that AMH could be used in the follow-up of patients with endometriosis, in order to assess promptly the decrease of ovarian reserve.

KW - Anti-Mullerian hormone

KW - Endometriosis

KW - Ovarian failure

KW - Ovarian reserve

UR - http://www.scopus.com/inward/record.url?scp=84891834655&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891834655&partnerID=8YFLogxK

U2 - 10.1016/j.ejogrb.2013.10.003

DO - 10.1016/j.ejogrb.2013.10.003

M3 - Article

C2 - 24210790

AN - SCOPUS:84891834655

VL - 172

SP - 62

EP - 64

JO - European Journal of Obstetrics, Gynecology and Reproductive Biology

JF - European Journal of Obstetrics, Gynecology and Reproductive Biology

SN - 0028-2243

IS - 1

ER -